Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LAURUS LABS Gains 3%; BSE HEALTHCARE Index Up 0.6%
Fri, 25 Oct 9:26

LAURUS LABS  Gains 3%; BSE HEALTHCARE Index Up 0.6%Image source: Chunumunu/www.istockphoto.com

LAURUS LABS share price has zoomed 3% and is presently trading at Rs 460.5.

Meanwhile, the BSE HEALTHCARE index is at 43,147.8 (up 0.6%).

Among the top gainers in the BSE HEALTHCARE index today are ASTER DM HEALTHCARE (up 2.1%) and AJANTA PHARMA (up 1.9%).

Procter & Gamble Health (down 2.1%) and CAPLIN POINT (down 1.1%) are among the top losers today.

Over the last one year, LAURUS LABS has moved up from Rs 361.6 to Rs 460.5, registering a gain of Rs 98.9 (up 27.3%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,503.7 to 43,147.8, registering a gain of 56.9% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 206.4%), Glenmark Pharma (up 124.1%) and SUVEN PHARMACEUTICALS (up 123.2%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 80,159.3 (up 0.1%).

The top gainers among the BSE Sensex today are Axis Bank (up 2.7%) and ITC (up 2.6%). The most traded stocks in the BSE Sensex are Indusind Bank and ITC.

In the meantime, NSE Nifty is at 24,393.2 . Indusind Bank and NTPC are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 64,571.9 to 80,159.3, registering a gain of 15,587.5 points (up 24.1%).

LAURUS LABS Financial Update...

LAURUS LABS net profit fell 54.9% YoY to Rs 177 million for the quarter ended September 2024, compared to a profit of Rs 393 million a year ago. Net sales declined 0.1% to Rs 12,237 million during the period as against Rs 12,245 million in July-September 2023.

For the year ended March 2024, LAURUS LABS reported 78.9% decrease in net profit to Rs 1,682 million compared to net profit of Rs 7,966 million during FY23. Revenue of the company fell 16.6% to Rs 50,408 million during FY24.

The current Price to earnings ratio of LAURUS LABS , based on rolling 12 month earnings, stands at 190.4.


Equitymaster requests your view! Post a comment on "LAURUS LABS Gains 3%; BSE HEALTHCARE Index Up 0.6%". Click here!